Baloxavir (Synonyms: BXA, S-033447) |
| Catalog No.GC19055 |
Baloxavir is an anti-influenza agent extracted from patent WO 2017104691 A1.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1985605-59-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Baloxavir is an anti-influenza agent extracted from patent WO 2017104691 A1.
References:
[1]. Shishido Takao, et al. Medicine for treating influenza characterized by comprising combination of cap-dependent endonuclease inhibitor with anti-influenza drug. WO 2017104691 A1.
Review for Baloxavir
Average Rating: 5 (Based on Reviews and 21 reference(s) in Google Scholar.)
Review for Baloxavir
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *